SK287115B6 - Farmaceutická kompozícia na parenterálne podávanie - Google Patents

Farmaceutická kompozícia na parenterálne podávanie Download PDF

Info

Publication number
SK287115B6
SK287115B6 SK726-2003A SK7262003A SK287115B6 SK 287115 B6 SK287115 B6 SK 287115B6 SK 7262003 A SK7262003 A SK 7262003A SK 287115 B6 SK287115 B6 SK 287115B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
alkali metal
cyclodextrin
composition according
dronedarone
Prior art date
Application number
SK726-2003A
Other languages
English (en)
Slovak (sk)
Other versions
SK7262003A3 (en
Inventor
Fr�D�Rique Bourriague-Seve
Thierry Breul
Original Assignee
Sanofi - Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi - Aventis filed Critical Sanofi - Aventis
Publication of SK7262003A3 publication Critical patent/SK7262003A3/sk
Publication of SK287115B6 publication Critical patent/SK287115B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
SK726-2003A 2000-12-11 2001-12-10 Farmaceutická kompozícia na parenterálne podávanie SK287115B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0016071A FR2817750B1 (fr) 2000-12-11 2000-12-11 Composition pharmaceutique de dronedarone pour administration parenterale
PCT/FR2001/003903 WO2002047660A1 (fr) 2000-12-11 2001-12-10 Composition pharmaceutique de dronedarone pour administration parenterale

Publications (2)

Publication Number Publication Date
SK7262003A3 SK7262003A3 (en) 2004-02-03
SK287115B6 true SK287115B6 (sk) 2009-12-07

Family

ID=8857483

Family Applications (1)

Application Number Title Priority Date Filing Date
SK726-2003A SK287115B6 (sk) 2000-12-11 2001-12-10 Farmaceutická kompozícia na parenterálne podávanie

Country Status (31)

Country Link
US (1) US6939865B2 (ja)
EP (1) EP1343473B1 (ja)
JP (1) JP4399161B2 (ja)
KR (1) KR100849758B1 (ja)
CN (1) CN1235566C (ja)
AR (1) AR031649A1 (ja)
AT (1) ATE348599T1 (ja)
AU (2) AU2002217229B2 (ja)
BG (1) BG66187B1 (ja)
BR (1) BR0116060B1 (ja)
CA (1) CA2427375C (ja)
CZ (1) CZ297788B6 (ja)
DE (1) DE60125411T2 (ja)
EA (1) EA005314B1 (ja)
FR (1) FR2817750B1 (ja)
HK (1) HK1055906A1 (ja)
HU (1) HU229372B1 (ja)
IL (2) IL155428A0 (ja)
IS (1) IS2349B (ja)
MA (1) MA26969A1 (ja)
ME (2) MEP20408A (ja)
MX (1) MXPA03005221A (ja)
NO (1) NO332294B1 (ja)
NZ (1) NZ525661A (ja)
OA (1) OA12416A (ja)
PL (1) PL199846B1 (ja)
RS (1) RS50348B (ja)
SK (1) SK287115B6 (ja)
TW (1) TWI246926B (ja)
WO (1) WO2002047660A1 (ja)
ZA (1) ZA200303406B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200800177A (en) * 2006-02-14 2008-01-01 Wyeth Corp Aqueous pharmaceutical formulations of ERβ selective ligands
GB0719180D0 (en) 2007-10-02 2007-11-14 Cambrex Karlskoga Ab New process
FR2930149B1 (fr) * 2008-04-17 2011-02-18 Sanofi Aventis Association de dronedarone avec au moins un diuretique, son application en therapeutique
AR072950A1 (es) 2008-04-17 2010-10-06 Sanofi Aventis Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad, composicion farmaceutica, articulo de fabricacion y envase
EP2116239A1 (en) * 2008-04-29 2009-11-11 Sanofi-Aventis Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
FR2959132A1 (fr) * 2010-04-22 2011-10-28 Sanofi Aventis Procedes pour l'evaluation et la reduction des risques
TWI508726B (zh) 2009-12-21 2015-11-21 Gilead Sciences Inc 治療心房纖維性顫動之方法
US20120005128A1 (en) * 2010-06-29 2012-01-05 Sanofi Methods for reducing the risk of an adverse dronedarone / calcium channel blockers interaction in a patient suffering from atrial fibrilation
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
CN102342907A (zh) 2010-07-30 2012-02-08 江苏恒瑞医药股份有限公司 决奈达隆固体分散体及其制备方法
KR20120094557A (ko) * 2011-02-01 2012-08-27 동아제약주식회사 피에이치 비의존적 용출양상을 갖는 부정맥치료제 제제
CN102908307A (zh) * 2011-08-03 2013-02-06 天津市嵩锐医药科技有限公司 供注射用盐酸决奈达隆药物组合物及其制备方法
SG11201500123XA (en) * 2012-07-12 2015-02-27 Sanofi Sa Anti-tumoral composition comprising the compound 1-(6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)-3-(2-morpholin-4-ylethyl)urea
WO2022083636A1 (zh) * 2020-10-20 2022-04-28 上海博志研新药物技术有限公司 盐酸决奈达隆药物组合物、其制备方法及应用
TW202320751A (zh) * 2021-08-16 2023-06-01 大陸商上海博志研新藥物技術有限公司 鹽酸決奈達隆注射組合物、其製備方法及應用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2746013B1 (fr) * 1996-03-18 1998-05-29 Sanofi Sa Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus
JP2004327321A (ja) * 2003-04-25 2004-11-18 Jst Mfg Co Ltd コネクタ

Also Published As

Publication number Publication date
ATE348599T1 (de) 2007-01-15
NO20031958D0 (no) 2003-04-29
HU229372B1 (en) 2013-11-28
HUP0500842A2 (hu) 2005-12-28
AU1722902A (en) 2002-06-24
BG107748A (bg) 2004-03-31
KR20030060985A (ko) 2003-07-16
AU2002217229B2 (en) 2006-05-18
IS2349B (is) 2008-04-15
FR2817750A1 (fr) 2002-06-14
CA2427375A1 (fr) 2002-06-20
CZ297788B6 (cs) 2007-03-28
PL362788A1 (en) 2004-11-02
WO2002047660A1 (fr) 2002-06-20
ME00083B (me) 2010-10-10
BR0116060B1 (pt) 2013-12-31
OA12416A (fr) 2006-04-18
DE60125411D1 (de) 2007-02-01
SK7262003A3 (en) 2004-02-03
CA2427375C (fr) 2011-02-01
IS6801A (is) 2003-04-30
NZ525661A (en) 2004-11-26
BR0116060A (pt) 2004-03-02
EA005314B1 (ru) 2004-12-30
EA200300406A1 (ru) 2003-10-30
ZA200303406B (en) 2004-05-03
CN1479610A (zh) 2004-03-03
IL155428A0 (en) 2003-11-23
JP2004528277A (ja) 2004-09-16
RS50348B (sr) 2009-11-10
FR2817750B1 (fr) 2003-02-21
MEP20408A (en) 2010-06-10
PL199846B1 (pl) 2008-11-28
KR100849758B1 (ko) 2008-07-31
EP1343473B1 (fr) 2006-12-20
YU46503A (sh) 2006-08-17
US6939865B2 (en) 2005-09-06
MXPA03005221A (es) 2004-03-26
CN1235566C (zh) 2006-01-11
NO332294B1 (no) 2012-08-20
JP4399161B2 (ja) 2010-01-13
TWI246926B (en) 2006-01-11
MA26969A1 (fr) 2004-12-20
EP1343473A1 (fr) 2003-09-17
NO20031958L (no) 2003-06-11
DE60125411T2 (de) 2007-10-11
US20040044070A1 (en) 2004-03-04
BG66187B1 (bg) 2011-12-30
AR031649A1 (es) 2003-09-24
IL155428A (en) 2007-10-31
HK1055906A1 (en) 2004-01-30
CZ20031612A3 (cs) 2003-09-17

Similar Documents

Publication Publication Date Title
EP2402008B1 (en) Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
SK287115B6 (sk) Farmaceutická kompozícia na parenterálne podávanie
JP2008542260A (ja) 新規の注射可能組成物及びその調製方法
JP2004526730A (ja) プロポフォール及びスルホアルキルエーテルシクロデキストリン含有製剤
KR100869752B1 (ko) 레보시멘단의 약학적 액제
JP4152118B2 (ja) １，２，３，９−テトラヒドロ−９−メチル−３−［（２−メチル−１ｈ−イミダゾール−１−イル）メチル］−４ｈ−カーバゾール−４−オンを有效成分とする鼻腔噴霧用組成物
KR100195348B1 (ko) 안정한 프로스타글란딘 e1-함유 주사제 조성물
JP2007500191A (ja) Ｃｃｉ−７７９の凍結乾燥処方
JP2009504634A (ja) プロポフォールを含む水性麻酔剤組成物
SK17162002A3 (sk) Farmaceutická forma podávania, spôsob jej výroby a použitia
SK1222001A3 (en) Pharmaceutical composition for injection based on paracetamol
US5886018A (en) Pharmaceutical composition for parenteral administration containing an indole-carboxylic acid
EP1002531A1 (en) A water-miscible composition of non-steroidal antiinflammatory drugs
JP4278115B2 (ja) キヌプリスチン及びダルホプリスチンに基づく安定化された製薬学的組成物並びにそれらの製造
US6187746B1 (en) Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof
CZ2001365A3 (cs) Farmaceutický prostředek pro injekce založený na paracetamolu

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20161210